171. Huffman L.B., Hartenbach E.M., Carter J., Rash J.K., Kushner D.M. Maintaining sexual health throughout gynecologic cancer survivorship: A comprehensive review and clini-cal guide. Gynecol Oncol. 2016 Feb;140(2):359-68. doi: 10.1016/j.ygyno.2015.11.010. Epub 2015 Nov 7. PubMed PMID: 26556768; PubMed Central PMCID: PMC4835814.
172. Carmody J.F., Crawford S., Salmoirago-Blotcher E., Leung K., Churchill L., Olendzki N. Mindfulness training for coping with hot flashes: results of a randomized trial. Menopause. 2011 June;18(6):611–20. DOI: 10.1097/gme.0b013e318204a05c.
173. Ferrandina G., Petrillo M., Mantegna G., Fuoco G., Terzano S., Venditti L., et al. Evaluation of quality of life and emotional distress in endometrial cancer patients: a 2-year prospective, longitudinal study. Gynecol Oncol. 2014 Jun;133(3):518-25. doi: 10.1016/j.ygyno.2014.03.015.
174. Armbruster S.D., Song J., Bradford A. et al. Sexual health of endometrial cancer survivors before and after a physical activity intervention: A retrospective cohort analysis. Gynecol Oncol 2016;143:589–595. Crossref, Medline, Google Scholar.
175. Lawvere, Silvana. (2002). The effect of massage therapy in ovarian cancer patients. doi: 10.1016/B978-0-7234-3217-3.50009-0
176. Hu H., Xie Z.G., Qin W.L. Effect of electroacupuncture intervention at different phases of post-operation on bladder function in patients undergoing cervical cancer operation. Zhen Ci Yan Jiu 2013;38:64–67, 77. Medline, Google Scholar.
177. Cannioto R.A., Moysich K.B. Epithelial ovarian cancer and recreational physical activity: A review of the epidemiological literature and implications for exercise prescription. Gynecol Oncol, 2015. 137(3): P. 559–73.
178. Hu M., Lin W. Effects of exercise training on red blood cell production: implications for anemia. Acta Haematol. 2012;127(3):156–64. Epub 2012 Jan 31.
179. Mustian K.M., Alfano C.M., Heckler C.. et al. Comparison of pharmaceutical, psy-chological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol 2017;3:961–968.
180. Kinkead B., Schettler P.J., Larson E.R., Carroll D., Sharenko M., Nettles J., et al. Massage therapy decreases cancer-related fatigue: Results from a randomized early phase trial. Cancer. 2018 Feb 1;124(3):546–554. DOI: 10.1002/cncr.31064.
181. Streckmann F., Zopf E.M., Lehmann H.C. et al: Exercise intervention studies in patients with peripheral neuropathy: a systematic review. Sports Med 2014;44:1289–1304.
182. Kleckner I.R., Kamen C., Gewandter J.S., et al. Effects of exercise during chemo-therapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized con-trolled trial. Support Care Cancer 2018;26:1019–1028.
183. Rick O., von Hehn U., Mikus E., Dertinger H., Geiger G. Magnetic field therapy in patients with cytostatics-induced polyneuropathy: A prospective randomized pla-cebo-controlled phase-III study. Bioelectromagnetics 2016; 38(2): 85–94.
184. Luchini, C. et al. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach Annals of Oncology, Volume 30, Issue 8, 1232 – 1243
185. Yukio Suzuki et al. Long-term survival outcomes for hormonal therapy in premenopausal patients with clinical stage I endometrial cancer.. JCO 42, 5508-5508(2024). DOI:10.1200/JCO.2024.42.16_suppl.5508
186. R. N. Eskander, M. W. Sill et al. Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer--N Engl J Med 388;23 nejm.org 2023;388:2159-2170 DOI: 10.1056/NEJMoa2302312 VOL. 388 NO. 2
187. Westin S, et al. durvalumab plus carboplatin/paclitaxel followed by maintenance durvalumab with or without Olaparib as first- line treatment for advanced endometrial cancer: The Phase III DUO-E trial. J Clin Oncol. 2023 Oct 21: JCO2302132.doi:10.1200/JCO.23.02132
188. García-Del-Muro X, López-Pousa A et al. Spanish Group for Research on Sarcomas. Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study. J Clin Oncol. 2011 Jun 20;29(18):2528-33. doi: 10.1200/JCO.2010.33.6107. Epub 2011 May 23. PMID: 21606430.
188. Трякин А.А., Бесова Н.С., Волков Н.М., Гладков О.А., Карасева В.В., Сакаева Д.Д. и соавт. Общие принципы проведения противоопухолевой лекарственной терапии. Практические рекомендации RUSSCO, часть 1. Злокачественные опухоли, 2023 (том 13), #3s2, стр. 28–41.
189. Serkies K, Baczkowska-Waliszewska Z. Adjuvant vaginal cuff brachytherapy in surgically treated endometrial carcinoma patients - in view of the recent evidence. J Contemp Brachytherapy. 2021 Apr;13(2):221-230. doi: 10.5114/jcb.2021.105291. Epub 2021 Apr 14. PMID: 33897797; PMCID: PMC8060967.
190. Lancellotta V, De Felice F et al.The role of vaginal brachytherapy in stage I endometrial serous cancer: a systematic review. J Contemp Brachytherapy. 2020 Feb;12(1):61-66. doi: 10.5114/jcb.2020.92698. Epub 2020 Feb 28. PMID: 32190072; PMCID: PMC7073340.
191. Shen JL, O'Connor KW, Moni J, Zweizig S, Fitzgerald TJ, Ko EC. Definitive Radiation Therapy for Medically Inoperable Endometrial Carcinoma. Adv Radiat Oncol. 2022 Oct 25;8(1):101003. doi: 10.1016/j.adro.2022.101003. PMID: 36711065; PMCID: PMC9873494.
192. Meric -Bernstam F et al. Efficacy and safety of trastuzumab deruxtecan in patients with HER2- expressing solid tumors: primary results from the DESTINY-Pan Tumor02, phase 2 trial. ( J Clin Oncol. 2023. Doi: 10.1200|JCO.23.02005
193. Багрова С. Г. Гранулоцитарные колониестимулирующие факторы в профилактике фибрильной нейтропении. /Эффективная фармакотерапия. /№31,-2015г/ Электронный доступ [https://umedp.ru/upload/iblock/278/bagrova.pdf]
194. Нечушкина В.М., Коломиец Л.А., Кравец О.А. и соавт. Рак тела матки и саркомы матки. Практические рекомендации RUSSCO, часть 1.2. Злокачественные опухоли 2024;14(3s2):165–188